Celecoxib for Primary Prophylaxis of Combat-Related Heterotopic Ossification

NCT01631669 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

100

Enrollment

FED

Sponsor class

Conditions

Ossification, Heterotopic

Interventions

DRUG: Celecoxib

Sponsor

Walter Reed National Military Medical Center